Detailed Search Results
| Author/Association: | Saunders EG, Pouliopoulou DV, Miller E, Billias N, MacDermid JC, Brunton L, Pereira TV, Quinn KL, Bobos P |
| Title: | Rehabilitation interventions and outcomes for post-COVID condition: a scoping review [with consumer summary] |
| Source: | BMJ Public Health 2025 Feb 26;3(e001827):Epub |
| Method: | systematic review |
| Method Score: | This is a systematic review. Systematic reviews are not rated. |
| Consumer Summary: | WHAT IS ALREADY KNOWN ON THIS TOPIC: Post-COVID condition (PCC) is commonly defined as the persistence or emergence of new symptoms at least 3 months after the initial SARS-CoV-2 infection, lasting for at least 2 months with no alternative explanation. PCC has significant impacts on both Canadian and global populations, yet no comprehensive intervention exists to address its full range of symptoms. WHAT THIS STUDY ADDS: This study provides a comprehensive synthesis of rehabilitation interventions and their corresponding outcomes for PCC. HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICY: The findings of this study aim to inform future research and evidence synthesis to enhance patient care and guide rehabilitation strategies for PCC. |
| Abstract: | OBJECTIVE: Several rehabilitation interventions have been proposed to support people with post-COVID-19 condition (PCC). However, the full spectrum of these interventions remains unclear, partly due to the complexity of PCC, which encompasses a broad range of symptoms affecting multiple organ systems and health domains. This scoping review aimed to identify the available rehabilitation interventions for PCC and the outcome measures used to evaluate them, to facilitate the development of multifaceted interventions and improve patient care. METHODS: Following the Joanna Briggs Institute Framework, we searched CINAHL, EMBASE, MEDLINE, PsychINFO, CENTRAL and Scopus databases from inception to 22 January 2024 for experimental and observational studies investigating rehabilitation interventions for adults with PCC. Interventions and their corresponding outcome measures were synthesised based on targeted outcomes aligned with the most common manifestations of PCC. The quality of intervention reporting was assessed using the Template for Intervention Description and Replication (TIDieR) checklist. RESULTS: We identified 74 studies; 28 randomised trials (37.8%) and 46 observational and quasi-experimental designs (62.2%). Most interventions consisted of different combinations of education, exercises and therapies to manage dyspnoea, fatigue and psychological symptoms, such as anxiety and depression. Few studies addressed postexertional malaise, cognitive function, memory, balance and coordination. At least half of the included studies required a confirmed SARS-CoV-2 infection for participant inclusion. Reporting on adherence rates was limited, and 65% of the studies did not report adverse events. CONCLUSION: There is a need for more comprehensive and inclusive approaches that address the full spectrum of PCC symptomatology to improve patient care and enhance the reproducibility of future studies. Full text (sometimes free) may be available at these link(s):  help |
